Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Semler Scientific (SMLR)

Semler Scientific (SMLR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Semler Scientific 2340-2348 Walsh Avenue Suite 2344 Santa Clara CA 95051 USA

www.semlerscientific.com P: 877-774-4211

Description:

Semler Scientific, Inc. is a medical risk-assessment company. The Company engages in developing, manufacturing, and marketing patented products that identify the risk profile of medical patients to allow healthcare providers to capture full reimbursement potential for their services. Its products include FloChec (R) which is used in the office setting to allow healthcare providers to measure arterial blood flow in the extremities and is a useful tool for internists and primary care physicians. Semler Scientific, Inc. is headquartered in Portland, Oregon.

Key Statistics

Overview:

Market Capitalization, $K 162,584
Enterprise Value, $K 105,254
Shares Outstanding, K 7,066
Annual Sales, $ 68,180 K
Annual Net Income, $ 20,580 K
Last Quarter Sales, $ 15,900 K
Last Quarter Net Income, $ 6,070 K
EBIT, $ 22,980 K
EBITDA, $ 23,580 K
60-Month Beta 0.92
% of Insider Shareholders 13.00%
% of Institutional Shareholders 49.37%
Float, K 6,147
% Float 87.00%
Short Volume Ratio 0.49

Growth:

1-Year Return -24.75%
3-Year Return -79.08%
5-Year Return -48.70%
5-Year Revenue Growth 217.26%
5-Year Earnings Growth 298.48%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.78 on 05/07/24
Latest Earnings Date N/A
Earnings Per Share ttm 2.79
EPS Growth vs. Prev Qtr 41.82%
EPS Growth vs. Prev Year 23.81%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

SMLR Ratios

Ratio
Price/Earnings ttm 8.48
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 30.36%
Return-on-Assets % 27.38%
Profit Margin % 30.18%
Debt/Equity 0.00
Price/Sales 2.45
Price/Cash Flow 7.68
Price/Book 2.14
Book Value/Share 11.08
Interest Coverage -1.73
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar